Search

Timothy J Pelura

from Malvern, PA
Age ~70

Timothy Pelura Phones & Addresses

  • 8 Woodford Ln, Malvern, PA 19355 (610) 296-1395
  • Media, PA
  • 11465 Forestview Ln, San Diego, CA 92131
  • Ewing, NJ
  • 26225 Bellemore Dr, Ramona, CA 92065
  • Atlanta, GA
  • Alameda, CA
  • 8 Woodford Ln, Malvern, PA 19355

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Resumes

Resumes

Timothy Pelura Photo 1

Timothy Pelura

View page
Location:
Greater Philadelphia Area
Industry:
Biotechnology
Timothy Pelura Photo 2

Timothy Pelura

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Timothy Pelura
Chairman, Principal
Biostrategy Partners Inc
Nonclassifiable Establishments
8360 Old York Rd, Melrose Park, PA 19027
Timothy J. Pelura
President, Chief Scientific Officer, Officer
Promedior, Inc
Mfg Pharmaceutical Preparations
371 Phoenixville Pike, Frazer, PA 19355
PO Box 456, Devault, PA 19432
(610) 560-1435, (610) 889-2203

Publications

Us Patents

Treatment Of Neurological Disease

View page
US Patent:
6689756, Feb 10, 2004
Filed:
Mar 4, 2002
Appl. No.:
10/090442
Inventors:
David P. Hesson - Malvern PA
Timothy J. Pelura - Malvern PA
Glen D. Frazer - Wynnewood PA
Assignee:
Integra LifeSciences Corporation - Plainsboro NJ
International Classification:
A61K 3170
US Classification:
514 43, 514192
Abstract:
Provided is, among other things, a method of treating in an animal infection or neoplasm of cerebrospinal tissue characterized by a risk of death, the method comprising: (a) injecting a physiologically acceptable fluid for cerebrospinal perfusion into a first catheter into the cerebrospinal pathway, which fluid for cerebrospinal perfusion has an therapeutically effective amount an agent, the agent selected for effectiveness against the infection as identified or diagnosed; (b) withdrawing fluid at a second catheter into the cerebrospinal pathway to create a flow and flow pathway between the first and second catheters; and (c) maintaining the flow for a period of time adapted to perfuse at least 1 CSF volume.

Conjoint Therapy For Treating Fibrotic Diseases

View page
US Patent:
8247370, Aug 21, 2012
Filed:
Dec 4, 2007
Appl. No.:
12/448035
Inventors:
Timothy J. Pelura - Malvern PA, US
Assignee:
Promedior, Inc. - Malvern PA
International Classification:
A61K 39/00
A61K 39/395
A61K 38/00
US Classification:
514 11, 4241301
Abstract:
The present invention relates to improved methods of treating fibrotic or fibroproliferative disorders. Conjoint therapies are provided comprising the combination of one or more fibrocyte suppressors and one or more profibrotic factor antagonists or anti-fibrotic agents.

Kits And Compositions Supporting Intracranial Perfusions

View page
US Patent:
20030060421, Mar 27, 2003
Filed:
Jul 19, 2001
Appl. No.:
09/908985
Inventors:
David Hesson - Malvern PA, US
Glenn Frazer - Wynnwood PA, US
Timothy Pelura - Malvern PA, US
Assignee:
Neuron Therapeutics, Inc.
International Classification:
A61K031/70
A61K031/198
A61K031/02
US Classification:
514/023000, 514/561000, 514/759000
Abstract:
Provided, among other things, is a kit providing pre-measured amounts of components to form a fluorocarbon nutrient emulsion capable of carrying oxygen to living tissue, the kit comprising: constituent solutions, emulsions or particle compositions, which are the constituent compositions, containing pre-measured amounts of components for making the fluorocarbon nutrient emulsion, the constituent compositions comprising: poly-fluorinated, oxygen-carrying compound; a physiologically acceptable emulsifying agent effective to emulsify the polymer; a nutrient-providing effective amount of carbohydrate; nutrient-providing effective amounts of amino acids or amino acid precursors; an oncotic agent in amount effective to provide, in conjunction with the other components of the solution, a physiologically acceptable oncotic pressure; and sufficient salts and buffering agents to provide a physiological osmotic pressure and physiologically appropriate concentrations of potassium and sodium ions; wherein constituent compositions are selected to allow for sufficient stability of the components to allow for commercial marketing of the kit.

Treatment Of Neurologic Hemorrhage

View page
US Patent:
20030135196, Jul 17, 2003
Filed:
Aug 28, 2002
Appl. No.:
10/229619
Inventors:
David Hesson - Malvern PA, US
Glen Frazer - Wynnewood PA, US
Timothy Pelura - Malvern PA, US
Barbara Powers - Phoenixville PA, US
Bruce Shook - Devon PA, US
Assignee:
Neuron Therapeutics, Inc. - Malvern PA
International Classification:
A61M031/00
US Classification:
604/500000, 424/531000
Abstract:
Subarachnoid hemorrhage is treated by circulating a synthetic cerebrospinal fluid containing an emulsifying agent in the cerebrospinal fluid pathway in the vicinity of hemorrhage. The emulsifying agent scavenges blood products and circulation of the synthetic cerebrospinal fluid clears the blood products form the subarachnoid space to reduce cerebral vasospasm.

Protection Of Neurological Tissue By Direct Cns Perfusion Cooling

View page
US Patent:
20030163181, Aug 28, 2003
Filed:
Dec 9, 2002
Appl. No.:
10/314870
Inventors:
Glenn Frazer - Wynnewood PA, US
David Hesson - Malvern PA, US
Timothy Pelura - Malvern PA, US
James Barnitz - Schwenksville PA, US
Assignee:
Neuron Therapeutics, Inc. - Malvern PA
International Classification:
A61F007/00
US Classification:
607/105000
Abstract:
Provided, among other things, is a method of treating, in an animal, an injury that is stroke, traumatic brain injury including traumatic surgical brain injury, brain hemorrhage other than stroke, spinal cord traumatic injury including spinal cord surgical trauma, infection, ischemia caused by surgical intervention, CNS injury caused by cardiac arrest, encephalitis or encephalomyelitis not due to infection, comprising: (a) creating a flow pathway, with an instillation catheter and an effluent catheter, that provides liquid flow in the vicinity of the injury; (b) instilling into the flow pathway an cerebrospinal perfusion fluid having a temperature from (i) 4 C. as a lower temperature to (ii) 4 C. below normal temperature of the animal; and (c) maintaining perfusion through the flow pathway for at least 12 hours of the cerebrospinal perfusion fluid having a temperature, at the point of instillation, from (i) 4 C. as a lower temperature to (ii) 4 C. below normal temperature of the animal.

Subarachnoid Spinal Catheter For Transporting Cerebrospinal Fluid

View page
US Patent:
20060184098, Aug 17, 2006
Filed:
Apr 21, 2003
Appl. No.:
10/543732
Inventors:
James Barnitz - Schwenksville PA, US
David Hesson - Malvern PA, US
Glenn Frazer - Wynnewood PA, US
Timothy Pelura - Malvern PA, US
Assignee:
Neuron Therapeutic, Inc. - Malvern PA
Integra LifeSciences Corporation - Plainsboro NJ
International Classification:
A61M 3/00
US Classification:
604043000
Abstract:
Provided is a multi-lumen intrathecal catheter capable of use for circulating a fluid through a portion of the spinal cord of a patient and having an insertable portion adapted for insertion into the spinal cord, comprising: a first lumen having a distal and a proximal end, the proximal end being adapted to being connected to a reservoir containing a fluid; a first fluid exchange section connected to the distal end of the first lumen having at least one inlet; a second lumen having a distal and a proximal end; and a second fluid exchange section connected to the distal and of the second lumen having at least one outlet, wherein at least one inlet and at least one outlet are offset from each other.

Fish Oil

View page
US Patent:
50231006, Jun 11, 1991
Filed:
Oct 2, 1989
Appl. No.:
7/415765
Inventors:
Stephen S. Chang - East Brunswick NJ
Yongde Bao - East Brunswick NJ
Timothy J. Pelura - Alameda CA
Assignee:
Kabi Vitrum AB
International Classification:
A23D 500
C11B 312
US Classification:
426601
Abstract:
An edible fish oil is disclosed which contains EPA and DHA. This oil, with significantly reduced undesirable impurities, is obtained by subjecting fish oil to vacuum steam distillation contacting the oil with an adsorbent and recovering the oil. The oil can be combined with a vegetable oil and/or Rosemary extract antioxidant to improve its oxidative stability.

Purification Of Fish Oil

View page
US Patent:
48746290, Oct 17, 1989
Filed:
May 2, 1988
Appl. No.:
7/189198
Inventors:
Stephen S. Chang - East Brunswick NJ
Yongde Bao - New Brunswick NJ
Timothy J. Pelura - Alameda CA
International Classification:
A23D 500
C11B 312
US Classification:
426601
Abstract:
A process of treating oils containing Omega-3 fatty acids, such as fish oils like Menhaden oil, sardine oil, salmon oil and other oils, to produce odorless and flavorless oils which contain only insignificant amounts of undesirable minor constituents, such as thermal and oxidative polymers of unsaturated glycerides, trans-isomers, positional isomers, conjugated dienes and trienes, cholesterols, pesticides, PCBs and heavy metals, and which have reasonably good flavor and oxidative stabilities.
Timothy J Pelura from Malvern, PA, age ~70 Get Report